Normal view MARC view ISBD view

Sirolimus-based immunosuppression is associated with increased survival after liver transplantation for hepatocellular carcinoma.

Toso, Christian

Sirolimus-based immunosuppression is associated with increased survival after liver transplantation for hepatocellular carcinoma. [electronic resource] - Hepatology (Baltimore, Md.) Apr 2010 - 1237-43 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

ISSN: 1527-3350

Standard No.: 10.1002/hep.23437 doi

Subjects--Topical Terms:
Adult
Aged
Carcinoma, Hepatocellular--mortality
Female
Humans
Immunosuppression Therapy
Immunosuppressive Agents--therapeutic use
Liver Neoplasms--mortality
Liver Transplantation
Male
Middle Aged
Sirolimus--therapeutic use

Print
Cite
Add to your cart (remove)
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)